Læknablaðið - 01.10.2014, Blaðsíða 15

LÆKNAblaðið 2014/100 511
til þess að að geta betur lagt mat á árangur í þessum undirhópi
sykursjúkra.
Lokaorð
Mikilvægt er að öðlast vitneskju um árangur kransæðahjáveitu-
aðgerða hjá sjúklingum með sykursýki, enda sykursýki vaxandi
heilsufarsvandamál og allt bendir til að þessi sjúklingahópur muni
fara stækkandi. Niðurstöður okkar benda til að skammtímaár-
angur eftir þessar aðgerðir sé góður, en samt lakari en þeirra sem
ekki eru sykursjúkir. Þessar upplýsingar ættu að nýtast til þess að
bæta árangur þessa sjúklingahóps enn frekar. Slíkt má gera með
ýmsum hætti, til dæmis með því að fyrirbyggja fylgikvilla og þá
sérstaklega varðveita nýrnastarfsemi, en nýrnaskaði er eitt helsta
vandamálið eftir þessar aðgerðir hjá sykursjúkum.
Þakkir
Þakkir fær Gunnhildur Jóhannsdóttir skrifstofustjóri á skurðsviði
fyrir aðstoð við öflun gagna.
Heimildir
1. Sigurjónsson H, Helgadóttir S, Oddsson SJ, Sigurðsson
MI, Geirsson A, Arnórsson T. Árangur kransæðahjáveitu-
aðgerða á Íslandi 2002-2006. Læknablaðið 2012; 98: 451-6.
2. Saely CH, Rein P, Vonbank A, Huber K, Drexel H. Type 2
diabetes and the progression of visualized atherosclerosis
to clinical cardiovascular events. Int J Cardiol 2012; 5: 5.
3. Tutun U, Ciçekçioğlu F, Budak B, Temürtürkan M, Parlar
AI, Seren M, et al. Coronary atherosclerosis distribution
and the effect of blood glucose level on operative morta-
lity/morbidity in diabetic patients undergoing coronary
artery bypass grafting surgery: a single center experience.
Anadolu Kardiyol Derg 2007; 7: 158-63.
4. Nishio E, Watanabe Y. Cigarette smoke extract inhibits
plasma paraoxonase activity by modification of the
enzyme‘s free thiols. Biochem Biophys Res Commun 1997;
236: 289-93.
5. Libby P, Ridker PM, Hansson GK. Progress and challenges
in translating the biology of atherosclerosis. Nature 2011;
473: 317-25.
6. de Winter RJ, Windhausen F, Cornel JH, Dunselman PH,
Janus CL, Bendermacher PE,et al. Early invasive versus
selectively invasive management for acute coronary syn-
dromes. N Engl J Med 2005; 353: 1095-104.
7. Mohr FW, Morice MC, Kappetein AP, Feldman TE, Ståhle
E, Colombo A, et al. Coronary artery bypass graft surgery
versus percutaneous coronary intervention in patients
with three-vessel disease and left main coronary disease:
5-year follow-up of the randomised, clinical SYNTAX trial.
Lancet 381: 629-38.
8. Guidelines on myocardial revasc. Eur Heart J 2010. ncbi.
nlm.nih.gov/pubmed/20802248.
9. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR,
Byrne JG, et al. 2011 ACCF/AHA Guideline for Coronary
Artery Bypass Graft Surgery: executive summary: a report
of the American College of Cardiology Foundation/
American Heart Association Task Force on Practice
Guidelines. Circulation 2011; 124: 2610-42.
10. Niles NW, McGrath PD, Malenka D, Quinton H,
Wennberg D, Shubrooks SJ, et al. Survival of patients
with diabetes and multivessel coronary artery disease
after surgical or percutaneous coronary revascularization:
results of a large regional prospective study. Northern
New England Cardiovascular Disease Study Group. J Am
Coll Cardiol 2001; 37: 1008-15.
11. Farkouh ME, Domanski M, Sleeper LA, Siami FS, Dangas
G, Mack M, et al. Strategies for multivessel revasculariza-
tion in patients with diabetes. N Engl J Med 2012; 367:
2375-84.
12. Shahian DM, O‘Brien SM, Filardo G, Ferraris VA, Haan
CK, Rich JB, et al. The Society of Thoracic Surgeons 2008
Cardiac Surgery Risk Models: Part 1—Coronary Artery
Bypass Grafting Surgery. Ann Thoracic Surg 2009; 88:
S2-S22.
13. Dalen M, Ivert T, Holzmann MJ, Sartipy U. Bilateral versus
single internal mammary coronary artery bypass grafting
in Sweden from 1997-2008. PLoS One 2014; 9: 21.
14. Swedeheart annual report. ncbi.nlm.nih.gov/pub-
med/25119891
15. CABG not PCI for adults with diabetes: BMJ. 2012 Nov
12;345:e7610. doi: 10.1136/bmj.e7610.
16. Aronson D, Edelman ER. Role of CABG in the manage-
ment of obstructive coronary arterial disease in patients
with diabetes mellitus. Curr Opin Pharmacol 2012; 12:
134-41.
17. Thorsson B, Aspelund T, Harris TB, Launer LJ, Gudnason
V. Þróun holdafars og sykursýki í 40 ár á Íslandi.
Læknablaðið 2009; 95: 259-66.
18. Bergsveinsson J, Aspelund T, Gudnason V, Benediktsson
R. Algengi sykursýki af tegund tvö á Íslandi 1967-2002.
Læknablaðið 2007; 93: 397-402.
19. Bansilal S, Farkouh ME, Hueb W, Ogdie M, Dangas G,
Lansky AJ, et al. The Future REvascularization Evaluation
in patients with Diabetes mellitus: optimal management
of Multivessel disease (FREEDOM) trial: clinical and
angiographic profile at study entry. Am Heart J 2012; 164:
591-9.
20. Leavitt BJ, Sheppard L, Maloney C, Clough RA, Braxton
JH, Charlesworth DC, et al. Effect of diabetes and associa-
ted conditions on long-term survival after coronary artery
bypass graft surgery. Circulation 2004; 110(11 Suppl 1):
II41-4.
21. Ascione R, Rogers CA, Rajakaruna C, Angelini GD.
Inadequate blood glucose control is associated with
in-hospital mortality and morbidity in diabetic and non-
diabetic patients undergoing cardiac surgery. Circulation
2008; 118: 113-23.
22. Landoni G, Bove T, Crivellari M, Poli D, Fochi O,
Marchetti C, et al. Acute renal failure after isolated CABG
surgery: six years of experience. Minerva Anestesiol 2007;
73: 559-65.
23. Carson JL, Scholz PM, Chen AY, Peterson ED, Gold J,
Schneider SH. Diabetes mellitus increases short-term
mortality and morbidity in patients undergoing coronary
artery bypass graft surgery. J Am Coll Cardiol 2002; 40:
418-23.
24. Pomposelli JJ, Baxter JK 3rd, Babineau TJ, Pomfret EA,
Driscoll DF, Forse RA, et al. Early postoperative glucose
control predicts nosocomial infection rate in diabetic
patients. JPEN J Parenter Enteral Nutr 1998; 22: 77-81.
25. Bell MR, Gersh BJ, Schaff HV, Holmes DR Jr, Fisher LD,
Alderman EL, et al. Effect of completeness of revas-
cularization on long-term outcome of patients with three-
vessel disease undergoing coronary artery bypass surgery.
A report from the Coronary Artery Surgery Study (CASS)
Registry. Circulation 1992; 86: 446-57.
26. Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C,
Goldstone AR, et al., EuroSCORE II. Eur J Cardiothorac
Surg 2012; 41: 734-44.
27. Howell NJ, Head SJ, Freemantle N, van der Meulen TA,
Senanayake E, et al. The new EuroSCORE II does not
improve prediction of mortality in high-risk patients
undergoing cardiac surgery: a collaborative analysis of
two European centres. Eur J Cardiothorac Surg 2013; 44:
1006-11.
28. Kellum JA, Bellomo R, Ronco C. The concept of acute
kidney injury and the RIFLE criteria. Contrib Nephrol
2007; 156: 10-6.
29. Alberti KG, Zimmet PZ. Definition, diagnosis and
classification of diabetes mellitus and its complications.
Part 1: diagnosis and classification of diabetes mellitus
provisional report of a WHO consultation. Diabet Med
1998; 15: 539-53.
30. Welborn TA, Wearne K. Coronary heart disease incidence
and cardiovascular mortality in Busselton with reference
to glucose and insulin concentrations. Diabetes Care 1979;
2: 154-60.
R a n n S Ó k n